PCN Insights, News, Videos, and More
Videos
10/27/2023
Featuring Rachel E. Salas, MD, MEd
Featuring Rachel E. Salas, MD, MEd
...
In this first installment of a video series on sleep disorder treatment through telehealth, Rachel E. Salas, MD, walks us through her experiences addressing sleep issues through telehealth versus in-person consultations.
In this first installment of a video series on sleep disorder treatment through telehealth, Rachel E. Salas, MD, walks us through her experiences addressing sleep issues through telehealth versus in-person consultations.
In this first installment of a...
10/27/2023
Psych Congress Network
News
10/25/2023
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting...
10/25/2023
Psych Congress Network
News
10/25/2023
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may...
10/25/2023
Psych Congress Network
News
10/23/2023
Emergency department (ED) visits for substance use, both with and without psychosis, were associated with an increased risk of developing schizophrenia spectrum disorder within 3 years.
Emergency department (ED) visits for substance use, both with and without psychosis, were associated with an increased risk of developing schizophrenia spectrum disorder within 3 years.
Emergency department (ED) visits...
10/23/2023
Psych Congress Network
Updates in Psychiatry
10/20/2023
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement...
10/20/2023
Psych Congress Network
News
10/19/2023
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug...
10/19/2023
Psych Congress Network
News
10/18/2023
Tom Valentino, Digital Managing Editor
A correlation between schizophrenia and somatic copy-number variants—a type of mutation that occurs early in development, but after genetic material is inherited—has been identified by Harvard Medical Institute researchers.
A correlation between schizophrenia and somatic copy-number variants—a type of mutation that occurs early in development, but after genetic material is inherited—has been identified by Harvard Medical Institute researchers.
A correlation between...
10/18/2023
Psych Congress Network
News
10/18/2023
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug...
10/18/2023
Psych Congress Network
Conference Coverage
10/17/2023
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents,...
10/17/2023
Psych Congress Network
Videos
10/16/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/16/2023
Psych Congress Network
